5th International Conference on Dementia and Alzheimer Rehabilitation

March 25-26, 2024 | Osaka, Japan

Theme: Decoding Dementia, Alzheimer’s disease and it's New Models of Care

About Conference
Sessions and Tracks
Market Analysis
About Conference

Scientific Meditech Conferences invites all the participants from all over the world to attend  5th International Conference on dementia and Alzheimer Rehabilitation during March 25-26, 2024 | Osaka, Japan with the Theme: Decoding Dementia, Alzheimer’s disease and  it's New Models of Care'' which includes keynote presentations, Oral talks, Poster presentations and Exhibitions.

 

Dementia & Alzheimer Rehabilitation conference raises the following questions :

  • What do you think are the biggest public misconceptions of DementiaVascular Dementia and Alzheimer's disease .
  • Will science ever discover a cure for Dementia, Vascular Dementia and brain health and memory disorders, including Alzheimer's disease, in older adults?
  • What recent scientific advances in treating or understanding Dementia, Vascular Dementia and Alzheimer's disease? Would you say you are most amped up for?
  • How will these change the diagnosis of the diseases.

Meet Inspiring Speakers and Experts at our Scientific Meditech Conferences with Unique Opportunity in Science, Medical and Technology field, which gives the online visibility to the Speakers, Experts and young researchers,”

 

Speaker Benefits at Dementia Conference 2024:-

 

Access to All Sessions

Conference-Handbook & Kit

Certificate of Presentation by International Organizing Committee (IOCM)

Advertisement of Company logo at Conference website

Constant source of fresh ideas and insights from Peers

Accepted Abstracts will be labeled with DOI

Career Development and Interactive sessions

Visibility of your profile across world

Creation one web page for each participant.

 

For any further information/queries, please send mail at: dementia@scientificmeditech.comdementiaconference18@gmail.com, dementiawebinar@gmail.com

Important Note:

Conference Date : March 25-26, 2024

Conference Venue: Osaka, Japan 

Abstract submission last date: 25 October, 2023

Sessions and Tracks

Sessions/ Tracks :

Track 1:    Dementia

Track 2:    Vascular Dementia

Track 3:    Dementia and Aging

Track 4:    Lewy body Dementia

Track 5:    Alzheimers Disease

Track 6:    Geriatrics Dementia

Track 7:    Cognitive Disorders

Track 8:    Neurodegenerative Diseases

Track 9:    Brain disorders

Track 10:  Dementia Nursing

Track 11:  Treating Dementia

Track 12:  Dementia Care Management

Track 13:  Neuropharmacology

Track 14:  Dementia Rehabilitation and Therapy

Track 15:  Novel Therapeutics

Track 16:  Case Reports

Market Analysis

Dementia & Alzheimer  is out broken as the major threat in the UK. It is stated that, by now there are around 810,000 people in UK with dementia & Alzheimer and the numbers are expected to rise to 1,152,677 by 2025 and 2,082,845 by 2050.

It is also reported that around 45 000 people below the age of 65 are suffering from early onset of dementia and 773,502 are in late onset of Dementia. 312,830 (38%) of people living with dementia over 65 are living in care homes (either residential care or nursing homes) and 473,639 (63%) are living in the community among the people. Based on the onset of disease, more people are prone to Dementia in the late onset period. During the late onset period i.e., between the age of 65 to 96* women develop the disease more frequently than men. There are more women patients and victims than men in the late onset case. During the early onset of the disease i.e., between the age group 30-65 men are more prone to the disease than women.

 Among the Dementia sub types, Alzheimer’s is the major type contributing to 64% among all the sub types, and amidst the other sub types next ranks the Vascular Dementia which contributes for about 18% of the cases. Next lies the mixed dementia which is ranking third in prevalence. The other sub types which include Dementia with Lewy bodies is found in 4% of people, Front temporal dementia in 3%, Parkinson’s dementia in 2%. The other associated diseases with dementia contribute around 5 % of the cases.

Dementia and Alzheimer’s with not only ruining the life of people also causes a major impact on the economy in the society. The greater part of the cost spent on Dementia care fall under three main categories health care cost, social care cost, informal care costs. The health care which includes hospitalization and treatment contributes about 16.4% of total cost, the social care which involves the care given by the nursing homes, home care contributes about 38 % of cost and the rest 45.6% comes under the informal care which the given by the family or friends related to the patient.

Speaker Opportunities : Oral Presentation, Poster Presentation, E-Poster

 

Renowned Speakers


Brandon Lucke-Wold
Department of Neurosurgery University of Florida, USA
David Truswell
CULTURE DEMENTIA, UK
Jacqueline Hinds
Wilson Hinds Consulting Ltd, UK
Giulia Frezza
ACLC & Metaphor Lab Amsterdam, University of Amsterdam, Netherlands
Tomoki Kaneko
Keio Research Institute at SFC, Japan
Mònica Mir Llorente
Institute for Bioengineering of Catalonia, Spain
Kelly Gibas
Bethel University, USA
Hansang Cho
Sungkyunkwan University, Republic of Korea
Konstantina Kotsaki, (Moderator)
University of Central Lancashire (UCLan), Greece
Amanda R. Cooper
The University of Arizona, USA
Liam Chen
University of Minnesota, USA
Gabriel Barreda Gómez
Director, IMG Pharma Biotech, Spain
M. Heather McKay
Partnerships for Health, USA
Jagoda Rusowicz
University School of Physical Education, Poland
Becky Wellman
Cleveland Clinic Lou Ruvo Center for Brain Health, USA
Najla Jouini
Institute of Technology, South Campus, Ireland
Iftach Dolev
CEO - QuantalX NeuroScience, Israel
Chuanhai Cao
University of South Florida, USA
Tetsuya Goto
Kagoshima University, Japan
Schupf, Nicole
The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, USA
Mr Tomofumi Tanno,
DAI Member And Advocate, Japan
Shohei Deguchi,
Japan
Ramesh Neelamegam
The University of Texas Health Science Center, USA
Alena Sidenkova
Alena Sidenkova Ural State Medical University, Russia
Jacqueline A Hinds
Society of Emotional Intelligence, UK
Margarita Letsou
Memorytainment, Greece

KEY TOPICS

  • Alzheimers Clinical Trials And Studies
  • Alzheimers Disease
  • Amnesia
  • Animal Models In Dementia
  • Anxiety
  • Autoimmune Disorders & Multiple Sclerosis
  • Behavioral Issues
  • Biopsychiatry
  • Blood-Brain Barrier
  • Brain Diagnosis
  • Brain Disease & Failure
  • Brain Injury
  • Brain Tumour
  • Central Nervous System
  • Cerebrovascular Disease
  • Child Neurology
  • Neural Engineering
  • Neural Enhancement
  • Neuro-Oncology
  • Neuroanaatomy
  • Neuroanatomy
  • Neurocritical Care
  • Neurotransmission
  • Neurotransmitters
  • Parkinson
  • Parkinsons Disease
  • CNS Tumors
  • Cognitive Disorders
  • Dementia
  • Dementia Care
  • Demyelination
  • Diagnosis And Therapy
  • Epilepsy
  • Genetics
  • Genetics And Epigenetics
  • Geriatric Neurology
  • Gut- Brain Axis
  • Headache
  • Intervention Neuroradiology
  • Meningitis
  • Mental Health
  • Mental Health Nursing
  • Metastatis
  • Movement Disorders
  • Multiple Sclerosis
  • Multiple Sclerosis Diagnosis
  • Nervous System
  • Neurodegeneration
  • Pediatric Neurology
  • Pharmacology
  • Psychiatry
  • Psychology
  • Neurodegenerative Disorder
  • Neurodegenerative Disorders
  • Neurogenetics
  • Neuroimaging
  • Neuroimmunology
  • Neurological Disorders
  • Neurological Disorders And Stroke
  • Neurological Infections
  • Neurological Surgery
  • Neurologist
  • Neurology
  • Neuromedicines
  • Neuromuscular Medicine
  • Neuronal Autoantibodies
  • Neuropathy
  • Neuropeptides
  • Neuropharmacology
  • Neuroscience
  • Neurosurgery
  • Neurotoxicology
  • Neurotoxins
  • Neurotransmission
  • Rehabilitation Therapy
  • Stem Cell Treatment For Neurological Disorders
  • Strokes
  • Traumatic Brain Injury
0
    0
    Your Cart
    Your cart is empty